| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BMS-195614 | CTRPv2 | pan-cancer | AAC | -0.051 | 0.2 |
| mRNA | BRD-K48334597 | CTRPv2 | pan-cancer | AAC | 0.088 | 0.2 |
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | 0.043 | 0.2 |
| mRNA | SU11274 | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | TPCA-1 | CTRPv2 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | -0.052 | 0.2 |
| mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | 0.047 | 0.2 |
| mRNA | MI-1 | CTRPv2 | pan-cancer | AAC | -0.052 | 0.2 |
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.043 | 0.2 |
| mRNA | BRD-K33199242 | CTRPv2 | pan-cancer | AAC | -0.05 | 0.2 |